
Florest50 mg
Everest Pharmaceuticals Ltd.
Fluvoxamine Maleate is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat obsessive-compulsive disorder and more.
Fluvoxamine Maleate is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat obsessive-compulsive disorder, and is also used in the management of depressive illness and certain anxiety-related conditions. Its indications can be classified by strength of evidence as follows:
The specific indication and duration of therapy with Fluvoxamine Maleate should always be determined by a qualified physician based on individual assessment.
Dosage of Fluvoxamine Maleate must be individualized by a physician according to the indication being treated, patient age, and response/tolerability. Treatment is generally started at a low dose and titrated gradually.
| Indication | Adult Dose | Pediatric Dose |
|---|---|---|
| Obsessive-Compulsive Disorder | Start 50 mg once daily at bedtime; increase in increments of 50 mg every 4-7 days as tolerated, up to a maximum of 300 mg/day. Total daily doses above 100 mg should be given in two divided doses (larger dose at bedtime). | Children/adolescents 8-17 years: start 25 mg once daily at bedtime; increase by 25 mg every 4-7 days. Maximum 200 mg/day (ages 8-11) or 300 mg/day (ages 12-17); doses above 50 mg/day divided. |
| Depression / Anxiety-related disorders | Start 50 mg once daily at bedtime; usual effective range 100-300 mg/day, titrated according to response. | Not established; not routinely recommended for depression in children. |
In patients with hepatic impairment, clearance of Fluvoxamine Maleate is reduced by approximately 30%; a lower starting dose with slow titration and close monitoring is recommended. Dose adjustment may also be needed in patients with significant renal impairment; consult a physician for individualized dosing.
Doses should be reduced gradually rather than abruptly discontinued, to minimize the risk of discontinuation symptoms (see Precautions and Warnings).
For detailed administration technique, see Administration. For quick-reference dosing figures, see Dosage.
Common side effects of Fluvoxamine Maleate (occurring in approximately 5% or more of patients) include:
Less common but more serious effects can include activation of mania/hypomania, seizures, abnormal bleeding, hyponatremia, and serotonin syndrome (see Precautions and Warnings for details). Any severe, persistent, or concerning side effect should be reported to a physician promptly.
Fluvoxamine Maleate is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.